As reported in previous research [10], the current study shows that patients with pSS who are positive for SSA, in contrast to those with positive ACA or healthy subjects, had a significantly higher proportion of CD19+ B cells, along with increased concentrations of globulin (GLB), IgG, IgA, and RF. This evidence concerns the gene CD79A and peeling skin syndrome.